research Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.
Search
forResearch
5 / 98 results 
research Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies
Fulvestrant solution doesn't help hair loss in men and postmenopausal women.
research Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
Generic Palbociclib is safe and tolerable for treating certain breast cancer types.
research Incidence of alopecia from endocrine therapies in cancer
Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.
research Onychomatricoma with classic features: Case report and review of the literature
Hair loss is a common side effect of hormone treatments for cancer.
Learn
5 / 801 resultslearn Ethinylestradiol
learn Ethynylestradiol
learn Alfatradiol
a synthetic estrogen used topically as an anti-androgen
learn Spironolactone
powerful topical and oral anti-androgen used mostly by women
learn Bicalutamide
a nonsteroidal anti-androgen, most commonly used orally for women
Community Join
— no results
Experts
— no results
Clinics
— no results